Andrea Charles | 11/21/2011
In this interview Hassan Bibi, Regional Regulatory Affairs Director NEWAAT - Janssen Pharmaceutical companies of Johnson and Johnson, speaks to Andrea Charles from Pharma IQ, about overcoming the 3 main challenges with regards to meeting regulatory approval and improving distribution operations across the Middle East. Bibi also shares his thoughts on the measures being taken to reduce counterfeiting in the pharmaceutical supply chain and how regulatory authorities and the pharmaceutical indust...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More